Clinical Trial Update: Alefacept in Kidney Transplant Recipients [NA]

View source ↗

Summary

The clinical trial evaluating alefacept in kidney transplant recipients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Alefacept (Alefacept)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Kidney Transplantation | NA | Status: WITHDRAWN